– INNA-051 increased early expression of multiple antiviral effector genes compared with placebo and shortened viral shedding duration in participants with confirmed influenza infection MELBOURNE, Australia and MILAN, Italy, Sept. 11, 2023 (GLOBE NEWSWIRE) — ENA Respiratory, a clinical-stage pharmaceutical company, announced positive data from the Phase 2a flu challenge study of INNA-051, a first-in-class, […]

Map of Arbor Metal Corp.’s Jarnet Lithium Claims VANCOUVER, British Columbia, Sept. 11, 2023 (GLOBE NEWSWIRE) — Arbor Metals Corp. (“Arbor” or the “Company”) (TSXV: ABR, FWB: 432 is pleased to announce the deployment of its exploration team to the Company’s Jarnet lithium project in the James Bay region of Quebec, Canada. The exploration program […]

Enters into a commercialization agreement for SB17, ustekinumab biosimilar candidate, in Europe and North America Partnership to support Samsung Bioepis pipeline expansion and provide increased access to biosimilars INCHEON, Korea, Sept. 11, 2023 (GLOBE NEWSWIRE) — Samsung Bioepis Co., Ltd. today announced that it has entered into a commercialization agreement with Sandoz for SB17, a […]

NEW YORK, Sept. 08, 2023 (GLOBE NEWSWIRE) — The Metals Company (Nasdaq: TMC) (“TMC” or “the Company”), an explorer of lower-impact battery metals from seafloor polymetallic nodules, intends to participate at the following in-person conferences being held by leading organizations and financial institutions during the third and fourth quarters of 2023. Recent company updates On […]